Liposcience Inc (LPDX) SEC Filing 8-K Material Event for the period ending Wednesday, September 24, 2014

Liposcience Inc

CIK: 1168197 Ticker: LPDX

View differences made from one to another to evaluate Liposcience Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 8-K Corporate News to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Liposcience Inc.


Assess how Liposcience Inc's management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Liposcience Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2014 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


Ticker: LPDX
CIK: 1168197
Form Type: 8-K Corporate News
Accession Number: 0001144204-14-057734
Submitted to the SEC: Thu Sep 25 2014 7:12:40 AM EST
Accepted by the SEC: Thu Sep 25 2014
Period: Wednesday, September 24, 2014
Industry: In Vitro And In Vivo Diagnostic Substances
  1. Event for Officers
  2. Financial Exhibit
  3. New Agreement
  4. Other Events

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: